- Advertisement -spot_img
Friday, September 30, 2022

Five researchers who move together to beat cancer from Navarra

They say that science is in their DNA, despite the difficulties involved in a research career in Spain, one of the least invested European countries for this purpose. Despite everything, they are grateful to be able to dedicate themselves to their passion, consider themselves privileged and not only roll up their sleeves in front of lab pipettes but also talk or attend schools. Huh inform society about science: what is investigated, where and how is the money received from them used. all in hand Spanish Association Against Cancer (AECC), which has research volunteers in this task of social awareness. “We thank the AECC for giving us this opportunity,” he says.

researchers like Mary White PrietoProfessor of Pharmaceutical Technology at the United Nations; Reuben Pio OasesDirector of the Border Solid Tumor Program; Carmen Flavor Lassert, Professor and Deputy Director of the Hepatology Program at Seema, where she also works Maria Arechedera Calderone And who has just joined as a young talent Carla Rojo Gonzalez, among others; Let’s stand today on World Cancer Research Day to emphasize the importance and, above all, that it should be invested. “It comes back in society. This has been seen with vaccines in the coronavirus pandemic,” Blanco says.

The AECC wants to put on the table this day disparities in access to research results and advances, a particularly serious problem in rare tumors and those with low survival rates. so ask Less than 30% of live or rare tumors are 100% detectable.

struggle for funding

Yes, considerable progress has been made in the diagnosis and treatment of cancer, but much remains to be done. ,Today more than half the tumors have been cured, You have to be optimistic”, says Rubén Pio. And by 2030 it is expected that cure will reach 70%, says Carmen Berasan. However, there are still tumors with low cure rates: pancreas, hepatocarcinoma, brain tumor or, rarely, etc. “Others, being very prevalent, continue to maintain high mortality rates, such as lung cancer,” Pio says.

Their work is focused on finding diagnostic markers that allow earlier detection of lung cancer and thus yielding new therapeutic strategies. “The only way to move forward is to investigate and discover new things. Don’t stop and raise funding if possible.” And there they report daily headaches.

“We Continue to Fight in Funding Calls”, You can always do more.” The fact that there is a private entity like the AECC, on which they depend for a significant portion of the investigation, shows that there is not enough support, they insist. Because if progress has been made it is because of research,” says Carmen Berasan.Policy makers need to be aware”, emphasizes Maria Blanco. And he insists that the pandemic has shown the importance of this work. “Millions of injections were done,” he says.

“If we want to compete with the rest of the world, be the leader and innovate, we have to invest in research. If not, we will always be behind”, says Bersain. “Leaders not in the long term. Think. Strategies are short-lived and there is no state policy to invest in many things, not just in research. Losing power,” he says.

decline in scientific professions

In fact, in addition to obtaining funding, one of the concerns of professionals is: decline in scientific professions Given the difficulties of building a professional career in the circumstances. “Profits are not immediate. They are bets in the medium or long term”, indicates Pío.

“It is now a reality that we are exporters of researchers,” says Carmen Berasan. “A lot is invested in teaching and training programs, for example for thesis, but then professionals go abroad And, in most cases, they cannot re-engage in research career”, says the expert. In the end, it’s the money and effort “that don’t go back”, he explains.

Maria Blanco expresses herself in similar words. After doing a thesis in France and working in Switzerland, he returned to Spain. “I spent years abroad until in 2000 they called me from the University of Navarra,” he says. “Now you look at young people and they don’t know what they’re going to do when they finish their thesis. Scientific professions collapse because They don’t see a future in Spain”, it says. And that the science being done in Spain is “very good,” says Bersan. “And the Spanish researchers are highly valued,” Pio says.

Continuity, essential to the researcher

Science’s new law, recently approved, is “inadequate,” they agree. ,Money is important, but consistency, You can have good people developing a project and in one call they don’t fund because there wasn’t enough budget”, explains Berasan. “They literally stop working. There is no security. We have to look for money every day to work”, he added.

In this context of instability, 23-year-old Carla Rojo González, a resident of La Rioja, graduated in biochemistry from the United Nations and began her thesis at SIMA, with a master’s degree in biomedical research specializing in cancer, with a scholarship. Thanks to that which allows him four years of continuity. ,I have coworkers who work as hard as they can; of waiters, I am lucky,” she says. “I also know that if I have to continue the investigation I will have to go abroad. We will see if I can come back. It is difficult”.

In this sense, experts point out that aid, grants and contracts from AECC tend to be of longer duration, allowing for greater continuity in projects.

diffusion science

For all these reasons, these researchers devote some part of their time to promote science In an effort to raise awareness of its relevance. “Very cutting-edge research is conducted that has nothing to envy about what is done overseas,” says Blanco. This professional focuses his work on nanomedicine applied to various diseases. “We tried a drug targeting only diseased cells. If you have a sick tree, you can set a whole forest on fire. This is done with current chemotherapy. We try to just set that tree on fire and leave the rest of the forest”, he says.

Maria Arechedera and Berasan work on liver cancer, reaching the limit with the help of AECC. “They have a poor survival. They are diagnosed late and there are no effective treatments. The aim, Arecadera indicates, is to improve the late diagnosis.” We want to identify biomarkers and advance that diagnosis. In addition, they are using bile to diagnose cholangiocarcinoma (a type of liver cancer) early. They are a prime example of the work that is being done in Navarra. and who eventually wants to return to the society.

World Nation News Desk
World Nation News Deskhttps://worldnationnews.com/
World Nation News is a digital news portal website. Which provides important and latest breaking news updates to our audience in an effective and efficient ways, like world’s top stories, entertainment, sports, technology and much more news.
Latest news
Related news
- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here